ImmunoPrecise Antibodies Ltd. IPA
1.62 0.00 (+0.00%)
Oct 20, 2025, 2:54 PM EDT
1.56 Day range 1.65
0.325 52-week range 2.60
Revenue & Expenses
Latest period ending Apr 30, 2025 · select a line to chart its full history
Income statement
| Fiscal year | FY 2025 Apr 30, 2025 | FY 2024 Apr 30, 2024 | FY 2023 Apr 30, 2023 | FY 2022 Apr 30, 2022 | FY 2021 Apr 30, 2021 |
|---|---|---|---|---|---|
| 24.52M | 24.52M | 20.66M | 19.36M | 17.91M | |
| 13.55M | 12.05M | 11.56M | 10.98M | 11.54M | |
| -33.56M | -29.12M | -28.40M | -16.75M | -6.92M | |
| -30.23M | -26.11M | -26.56M | -16.71M | -7.34M | |
| -0.91 | -1.02 | -1.07 | -0.85 | -0.45 |
Balance sheet
| Fiscal year | FY 2025 Apr 30, 2025 | FY 2024 Apr 30, 2024 | FY 2023 Apr 30, 2023 | FY 2022 Apr 30, 2022 | FY 2021 Apr 30, 2021 |
|---|---|---|---|---|---|
| 10.79M | 3.54M | 8.37M | 30.05M | 41.84M | |
| 44.44M | 59.99M | 77.81M | 93.65M | 66.96M | |
| 20.82M | 24.31M | 20.01M | 18.36M | 10.04M | |
| 13.40M | 13.68M | 7.27M | 2.77M | 3.46M | |
| 23.63M | 35.68M | 57.80M | 75.28M | 56.92M |
Cash flow
| Fiscal year | FY 2025 Apr 30, 2025 | FY 2024 Apr 30, 2024 | FY 2023 Apr 30, 2023 | FY 2022 Apr 30, 2022 | FY 2021 Apr 30, 2021 |
|---|---|---|---|---|---|
| -6.41M | -3.18M | -19.83M | -9.92M | -600.00K | |
| -799.00K | -1.56M | -1.97M | -5.21M | -2.46M | |
| 14.89M | 1.02M | -621.00K | 2.88M | 43.38M | |
| -799.00K | -1.40M | -1.50M | -1.26M | -1.43M | |
| 7.68M | -3.73M | -22.42M | -12.25M | 40.32M |